SUBSCRIBE TODAY!
Subscribing entitles a reader to complete stories on all topics released as they happen, special features, confidential documents and access to the complete, searchable story archive online back to 2004.

Advertisement


Inside Views

Submit ideas to info [at] ip-watch [dot] ch!

We welcome your participation in article and blog comment threads, and other discussion forums, where we encourage you to analyse and react to the content available on the Intellectual Property Watch website.

By participating in discussions or reader forums, or by submitting opinion pieces or comments to articles, blogs, reviews or multimedia features, you are consenting to these rules.

1. You agree that you are fully responsible for the content that you post. You will not knowingly post content that violates the copyright, trademark, patent or other intellectual property right of any third party or which you know is under a confidentiality obligation preventing its publication and that you will request removal of the same should you discover that you have violated this provision. Likewise, you may not post content that is libelous, defamatory, obscene, abusive, that violates a third party's right to privacy, that otherwise violates any applicable local, state, national or international law, that amounts to spamming or that is otherwise inappropriate. You may not post content that degrades others on the basis of gender, race, class, ethnicity, national origin, religion, sexual preference, disability or other classification. Epithets and other language intended to intimidate or to incite violence are also prohibited. Furthermore, you may not impersonate others.

2. You understand and agree that Intellectual Property Watch is not responsible for any content posted by you or third parties. You further understand that IP Watch does not monitor the content posted. Nevertheless, IP Watch may monitor the any user-generated content as it chooses and reserves the right to remove, edit or otherwise alter content that it deems inappropriate for any reason whatever without consent nor notice. We further reserve the right, in our sole discretion, to remove a user's privilege to post content on our site. IP Watch is not in any manner endorsing the content of the discussion forums and cannot and will not vouch for its reliability or otherwise accept liability for it.

3. By submitting any contribution to IP Watch, you warrant that your contribution is your own original work and that you have the right to make it available to IP Watch for all purposes and you agree to indemnify IP Watch, its directors, employees and agents against all damages, legal fees and others expenses that may be incurred by IP Watch as a result of your breach of warranty or of these terms.

4. You further agree not to publish any personal information about yourself or anyone else (for example telephone number or home address). If you add a comment to a blog, be aware that your email address will be apparent.

5. IP Watch will not be liable for any loss including but not limited to the following (whether such losses are foreseen, known or otherwise): loss of data, loss of revenue or anticipated profit, loss of business, loss of opportunity, loss of goodwill or injury to reputation, losses suffered by third parties, any indirect, consequential or exemplary damages.

6. You understand and agree that the discussion forums are to be used only for non-commercial purposes. You may not solicit funds, promote commercial entities or otherwise engage in commercial activity in our discussion forums.

7. You acknowledge and agree that you use and/or rely on any information obtained through the discussion forums at your own risk.

8. For any content that you post, you hereby grant to IP Watch the royalty-free, irrevocable, perpetual, exclusive and fully sub-licensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such content in whole or in part, world-wide and to incorporate it in other works, in any form, media or technology now known or later developed.

9. These terms and your posts and contributions shall be governed and interpreted in accordance with the laws of Switzerland (without giving effect to conflict of laws principles thereof) and any dispute exclusively settled by the Courts of the Canton of Geneva.

How Listing Ukraine As A Priority Foreign Country In Special 301 Violates WTO Agreements

Prof. Sean Flynn asks whether US sanctions of Ukraine under the US Special 301 program violates World Trade Organization rules. He also asks whether the operation of watch lists threatening sanctions for intellectual property matters could be challenged under the WTO even prior to any sanction going into effect.





Latest Comments
  • As it happens, I own and create "intellectual prop... »
  • So long term planning of the UN Development Decade... »

  • For IPW Subscribers
    A directory of IP delegates in Geneva. Read more>

    A guide to Geneva-based public health and intellectual property organisations. Read More >

    Monthly Reporter

    The Intellectual Property Watch Monthly Reporter, published from 2004 to January 2011, is a 16-page monthly selection of the most important, updated stories and features, plus the People and News Briefs columns.

    The Intellectual Property Watch Monthly Reporter is available in an online archive on the IP-Watch website, available for IP-Watch Subscribers.

    Access the Monthly Reporter Archive >


    Finance

    08/05/2013: WTO Announces Next Step For Azevedo To Become New Director
    11/04/2013: Reports: Obama’s Proposed 2014 Budget Favours Patent Office, R&D, Generic Drugs
    09/04/2013: Health Research Colloquium Calls On Countries To Invest More In R&D
    25/03/2013: Global Fund Receives USD 1.65B From US Congress; Names New Board Leadership
    23/03/2013: US Supreme Court To Hear Arguments On Pay-For-Delay Drug Deals
    22/03/2013: Conference Addresses Current Issues For Corporate IP Counsel
    18/03/2013: Tuberculosis: WHO, Global Fund Call For Mobilisation Of Funds As Resistance Rises
    18/03/2013: Practitioners Discuss Interconnection Between Professional Sports And IP
    11/03/2013: Swiss Perspectives On The Success Of Its National Innovation Model
    05/03/2013: “Works For Hire” A Key Issue As Music Stars Begin Terminating Copyright Transfers
    04/03/2013: Patent Pool-ViiV Collaboration On Paediatric HIV Sparks Reactions, Hope
    01/03/2013: Global Fund Launches New Funding Model
    27/02/2013: Recording Industry Sees New “Buzz” From Digital Revenues
    21/02/2013: European Commission Seeks Comments On Licensing For Tech Transfer
    13/02/2013: President Obama Calls For Dramatic Increase In R&D, Major Trade Deals
    12/02/2013: Report Finds Average US Patent Cost US$ 374,000 In 2012
    12/02/2013: Letter Shows US Pressure On Global Fund For Compulsory Licensing, Generics
    05/02/2013: European Commission Launches Copyright Licensing Initiative
    04/02/2013: FAO: New GMOs Rising In Developing Countries; Public Sector Key
    31/01/2013: Mediator’s Report On EU Copyright Levies Recommends Major Changes
    30/01/2013: WHO Executive Board Concludes After ‘Unpredecented’ Workload
    29/01/2013: Inside Views: Potential Elements Of The WHO Global R&D Treaty: Tailoring Solutions For Disparate Contexts
    28/01/2013: WHO Board Approves Resolution On Neglected Diseases; Sets Action On Substandard Medicines
    28/01/2013: Debate Erupts At WHO Over “Consensus” On Financing R&D For The Poor
    18/01/2013: Official Offers Reflections On WHO Reform, Private Sector Role
    16/01/2013: Free Drugs Are “Crucial Part” Of Neglected Tropical Disease Fight
    15/01/2013: Company Takes A Fair Shot At Facebook, LinkedIn, With Social Networking Patents
    10/01/2013: EPO Staff To Get Disputed €28M Bonus, Despite Protest
    09/01/2013: IP-Watch Looks At The Year Ahead In International IP Policy
    02/01/2013: Inside Views: Collaborative Capacity Building In Intellectual Property — Leveraging On African Diaspora Exchange
    29/11/2012: WHO Members Agree On “Strategic Work Plan” On Health R&D – But No Convention
    29/11/2012: WHO Negotiations To Address Medical R&D Global Gaps Head Deep Into Night
    28/11/2012: International Instrument On Medical R&D Still On Negotiating Table At WHO
    27/11/2012: UNITAID: Alternative Funding Mechanism For AIDS Drugs Saving Lives
    27/11/2012: Special Report: With Poor And Uninsured A Majority, Southeast Asia Sees Rise In Generics
    25/11/2012: WHO Members Meet This Week To Address Global Gaps In Medical R&D
    16/11/2012: Study: UN Development Needs Reform; US, Indian Ambassadors Agree
    15/11/2012: EU Parliament, Scientists Press Governments To Boost Research Funding
    13/11/2012: Proposal For EPO Staff Bonus Raises Questions
    12/11/2012: Next Global Fund Director To Be Chosen From Four Candidates This Week
    09/11/2012: Technical Meeting Advances Ideas For WHO-Led R&D Financing Framework
    22/10/2012: UN: Governments To Double Biodiversity Funding, Push Access/Benefit-Sharing
    18/10/2012: Pro-Music Re-Launched After Nine Years
    15/10/2012: EU Rights Owners Blast ICT Industry For Trying To “Hijack” Copyright Levy System Talks
    08/10/2012: At WHO, Pharma Suggests Payment Plan For Influenza Virus Use
    07/10/2012: OECD Report Shows Rise Of Internet Services
    05/10/2012: Google, Publishers Reach Digital Library Settlement
    28/09/2012: Industry Analysis: Print Sales Still In Decline; New Copyright Law Not A Solution
    25/09/2012: European Creators Insist Private Copying Levy Still Relevant
    25/09/2012: Special Report: Licensing Of News Titles And Extracts – Newspapers’ Best And Last Bet?
    Your IP address is 23.22.76.170